Status:
UNKNOWN
Methodology for Developing an Occlusal Appliance With CBD Active Carrier
Lead Sponsor:
Medical University of Silesia
Conditions:
Temporomandibular Disorder
Myofascial Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients
Detailed Description
Occlusal appliance therapies are used in TMD patients. In this research the active CBD molecules will be released from the occlusal appliance during nighttime, in population of patients suffering from...
Eligibility Criteria
Inclusion
- patient agreement to take part in the study
- RDC/TMD group Ia and Ib
- Bruxism Index\> 3 ( Brux-off polysomnography)
Exclusion
- CBD allergy/hypersensitivity/ addiction
- Therapy with analgesic drugs
- Therapy with drugs affecting muscle function
- Fixed or removable dental prosthesis
- Ongoing orthodontic treatment
- Other general disorders affecting muscle tension
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04775030
Start Date
January 1 2021
End Date
January 1 2023
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of TMD Silesian Medical University
Zabrze, Poland, 41-800